文献速递头颈神经CTPET

采用99Tcm-二乙烯三胺五乙酸SPECT/CT的校正最大标准化摄取值及摄取比值评估甲状腺相关眼病活动性

Assessment of thyroid-associated ophthalmopathy activity using corrected standardised uptake value maximum (SUVmax) and uptake ratios from 99Tcm-diethylene triamine pentaacetic acid single photon emission computed tomography/computed tomography (99Tcm-DTPA SPECT/CT) imaging.
PubMed 文献 · Clin Radiol · 2025-05-06

本研究纳入83例甲状腺相关眼病患者166个眼眶及11名健康对照22个眼眶,用99Tcm-DTPA SPECT/CT测量校正SUVmax和摄取比值(UR)。活动组校正SUVmax和UR显著高于非活动组和对照组(P<0.001);校正SUVmax与临床活动度评分(CAS)正相关(rs=0.537,P<0.001),重复性好(ICC=0.958),阈值10.440预测TAO活动性的敏感度70.7%、特异度82.1%。

要点

  • 活动组校正SUVmax和UR显著高于非活动组和对照组(P<0.001)。
  • 校正SUVmax阈值10.440预测TAO活动性:敏感度70.7%、特异度82.1%。
  • 校正SUVmax与CAS正相关(rs=0.537,P<0.001),观察者间一致性ICC=0.958。

核心结论

  • 校正SUVmax与CAS强相关且观察者间一致性高,是量化TAO炎症活动的可靠参数,可能用于指导TAO治疗和监测疾病进展。

研究设计与样本

  • 共分析83例TAO患者166个眼眶及11名健康对照22个眼眶;按CAS分为活动组(CAS≥3)、非活动组(CAS<3)和对照组;用Q.Metrix软件定量测量校正SUVmax和UR;采用Kruskal-Wallis检验、Spearman相关和ROC曲线评估。

诊断标准与关键数值

  • 校正SUVmax阈值10.440预测TAO活动性:敏感度70.7%、特异度82.1%;校正SUVmax重复性ICC=0.958,UR重复性ICC=0.632;校正SUVmax与CAS正相关(rs=0.537,P<0.001)。

临床应用与阅片要点

  • 作者认为校正SUVmax与CAS强相关且观察者间一致性高,可能用于指导TAO治疗和监测疾病进展。

局限性

  • 原文指出需进一步多中心研究验证这些发现并扩展临床应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: This study evaluated the utility of corrected maximum standardized uptake value (SUVmax) in assessing thyroid-associated ophthalmopathy (TAO) activity through 99Tcm-diethylene triamine pentaacetic acid (99Tcm-DTPA) SPECT/CT imaging.

MATERIALS AND METHODS: A total of 166 orbits from 83 TAO patients were analyzed, alongside 22 orbits from 11 healthy controls. Participants were cate gorized into active (CAS ≥ 3), inactive (CAS <3), and control groups based on the clinical activity score (CAS). Corrected SUVmax and uptake ratios (UR) were quantitatively measured using Q.Metrix software. Statistical analyses, including Kruskale-Wallis tests, Spearman correlations, and ROC curve evaluations, were employed to examine group differences and diagnostic performance.

RESULTS: The corrected SUVmax and UR values were significantly higher in the active group compared to inactive and control groups (P<0.001). Corrected SUVmax demonstrated strong reproducibility (ICC = 0.958) and a positive correlation with CAS (rs = 0.537, P<0.001), outperforming UR in consistency (ICC = 0.632). ROC analysis revealed that the corrected SUVmax threshold of 10.440 offered 70.7% sensitivity and 82.1% specificity for predicting TAO activity. UR exhibited comparable diagnostic performance but with reduced reproducibility.

CONCLUSION: These findings highlight corrected SUVmax as a robust and reliable parameter for quantifying TAO inflammatoryactivity. Its strong correlation with CAS and high interobserver agreement establish its potential for clinical use in guiding TAO treatment and monitoring disease progression. Further multicenter studies are warranted to validate these findings and expand clinical applications.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Sun J, Ma L, Wang M, et al. Assessment of thyroid-associated ophthalmopathy activity using corrected standardised uptake value maximum (SUVmax) and uptake ratios from 99Tcm-diethylene triamine pentaacetic acid single photon emission computed tomography/computed tomography (99Tcm-DTPA SPECT/CT) imaging. Clin Radiol. 2025. PMID: 40450787. doi:10.1016/j.crad.2025.106946

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。